Claret Asset Management Corp Maravai Lifesciences Holdings, Inc. Transaction History

Claret Asset Management Corp

  • $611 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$6.87 - $11.34 $97,780 - $161,402
14,233 Added 130.01%
25,181 $180,000
Q1 2024

Apr 29, 2024
SELL
$5.11 - $8.76 $4,404 - $7,551
-862 Reduced 7.3%
10,948 $95,000
Q4 2023

Feb 12, 2024
BUY
$4.7 - $9.87 $620 - $1,302
132 Added 1.13%
11,810 $77,000
Q2 2023

Aug 09, 2023
BUY
$12.09 - $15.0 $141,187 - $175,170
11,678 New
11,678 $145,000

Others Institutions Holding MRVI

# of Institutions
234
Shares Held
140M
Call Options Held
223K
Put Options Held
19.4K
View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI Quotes by TradingView
  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email